SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

EXACT Sciences Corporation – ‘8-K’ for 2/16/21

On:  Tuesday, 2/16/21, at 4:07pm ET   ·   For:  2/16/21   ·   Accession #:  1124140-21-26   ·   File #:  1-35092

Previous ‘8-K’:  ‘8-K’ on 1/15/21 for 1/11/21   ·   Next:  ‘8-K’ on / for 3/3/21   ·   Latest:  ‘8-K’ on / for 5/4/21

Magnifying glass tilted right emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/16/21  EXACT Sciences Corporation        8-K:2,9     2/16/21   13:342K

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     26K 
 2: EX-99       Miscellaneous Exhibit                               HTML     66K 
 9: R1          Cover Page                                          HTML     46K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- exas-20210216_htm                   XML     21K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.CAL  XBRL Calculations -- exas-20210216_cal               XML      7K 
 5: EX-101.DEF  XBRL Definitions -- exas-20210216_def                XML      9K 
 6: EX-101.LAB  XBRL Labels -- exas-20210216_lab                     XML     68K 
 7: EX-101.PRE  XBRL Presentations -- exas-20210216_pre              XML     33K 
 3: EX-101.SCH  XBRL Schema -- exas-20210216                         XSD     11K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    18K 
13: ZIP         XBRL Zipped Folder -- 0001124140-21-000026-xbrl      Zip     24K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  exas-20210216  
 i 0001124140 i false00011241402021-02-162021-02-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM  i 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):   i February 16, 2021
 
 i EXACT SCIENCES CORPORATION
(Exact Name of Registrant as Specified in Charter)
 
 i Delaware  i 001-35092  i 02-0478229
(State or Other Jurisdiction
of Incorporation)
 (Commission
File Number)
 (I.R.S. Employer
Identification No.)
 
 i 5505 Endeavor Lane
 i Madison,  i WI   i 53719
(Address of Principal Executive Offices)(Zip Code)
 
Registrant’s telephone number, including area code:  ( i 608)  i 284-5700
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 i             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 i            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 i             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 i            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
 i Common Stock, $0.01 par value per share i EXAS i The Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  i 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



2.02.                     Results of Operations and Financial Conditions.
 
On February 16, 2021, Exact Sciences Corporation announced its financial results for the quarter and full year ended December 31, 2020.  A copy of the press release is being furnished as Exhibit 99 to this Current Report on Form 8-K.

The information in this Current Report on Form 8-K and Exhibit 99 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
 
9.01.                     Financial Statements and Exhibits.
 
Exhibits
 
The exhibits required to be filed as a part of this Current Report on Form 8-K are listed below and incorporated herein by reference.
  
Exhibit No. Exhibit Description
   
 Press release, dated February 16, 2021, issued by Exact Sciences Corporation, furnished herewith.
   
104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

2



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 EXACT SCIENCES CORPORATION
   
Date: February 16, 2021By:/s/ Jeffrey T. Elliott
  Jeffrey T. Elliott
  Chief Financial Officer

3

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:2/16/21SC 13G,  SC 13G/A
12/31/20
 List all Filings 
Top
Filing Submission 0001124140-21-000026   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2021 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 14, 5:52:03.0am ET